Arrhythmias and Left Ventricular Hypertrabeculation/Noncompaction

Author(s): C. Stollberger, J. Finsterer

Journal Name: Current Pharmaceutical Design

Volume 16 , Issue 26 , 2010

Become EABM
Become Reviewer
Call for Editor


Arrhythmias in left ventricular hypertrabeculation/noncompaction (LVHT) comprise sustained or non-sustained ventricular tachycardia (VT) (n=135), atrial fibrillation (AF) (n=96) AV block (n=55) and QT prolongation (n=47). The prevalence differs between children and adults. In children most frequent are WPW-syndrome (n=24), AV block (n=24), VT (n=17) and bradycardia (n=15). In adults most frequent arrhythmias are VT (n=118), AF (n=95), QT prolongation (n=42) and AV block (n=31). Some arrhythmias are more frequently reported in children than in adults like WPW-syndrome (24 vs. 17 patients), second-degree AV block (4 vs. 0 patients), bradycardia (15 vs. 3 patients) and ventricular fibrillation (VF) (9 vs. 5 patients). There are nearly no pediatric cases with AF (1 vs. 95 patients). In 120 patients implantable cardioverters/defibrillators have been implanted for primary or secondary prevention of sudden cardiac death. The pathomechanisms of arrhythmias in LVHT are largely unknown, especially if patients with LVHT and neuromuscular disorders are more prone to arrhythmias than patients without. There is a need to clarify risk factors for VT or VF because 19% of LVHT patients with VT or VF have a normal systolic function and demonstration of systolic dysfunction is no reliable risk marker. Data about long-term follow- up of LVHT patients with implanted cardioverters/defibrillators are necessary since the indication for prophylactic implantation is still unclear. AF in LVHT increases the embolic risk, thus it would be useful to know which LVHT patients who have sinusrhythm at baseline are prone to develop AF in order to start early with anticoagulant therapy.

Keywords: Atrial fibrillation, ventricular tachycardia, ventricular fibrillation, atrio-ventricular block, noncompaction, neuromuscular disorder, implantable cardioverter defibrillator, Arrhythmias, left ventricular hypertrabeculation, neuromuscular disorders, prophylactic implantation, anticoagulant therapy, echocardiography, spongy myocardium, persisting sinusoids, rheumatic heart disease, Wolff-Parkinson-White, vitamin-K-antagonists, implantable cardioverter-defibrillator (ICD), Paroxysmal, spherocytosis, mitral stenosis, Dyspnoea, amiodarone, transesophageal echocardiography, Supraventricular tachycardia, acetylsalicylic acid, sinusrhythm, mexiteline hydrochloride, vesicouretral reflux, gadolinium, Mahaim Fibers, Atriofascicular, Ebstein's anomaly, atrial septal aneurysm, mitral valve cleft, Sick sinus syndrome, Atrial standstill, Kasai portoenterostomy, myoadenylate-deaminase deficiency, warfarin therapy, haematothorax, prophylaxis, Sudden cardiac death

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [2880 - 2894]
Pages: 15
DOI: 10.2174/138161210793176518
Price: $65

Article Metrics

PDF: 25